ArticleBritish journal of cancer2013

Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma.

K Yoshimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.